Learn how antibody discovery is changing in today’s therapeutic space. Case studies presented by Abveris highlight accelerated development of next-generation antibody therapeutics.
Watch this on-demand presentation from the 2020 LabRoots Coronavirus Webinar Series to find out how B Cell Antibody Discovery has allowed Berkeley Lights collaborators to discover >500 antibodies to SARS-CoV-2 in a single day.
Find out how Abveris is transforming their antibody discovery processes with the Beacon® optofluidic system.
Dr. Shireen Khan presents a case study on how ChemPartner has leveraged the Beacon system to rapidly discover cross-reactive antibodies against the GPI-anchored uPA receptor.